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5%( 7.5%( 10%( 12%( 15%(
Distiled!Water! 12.3! 10.93! 9.68! 8.68! 7.18!
1.5M!Tris,!pH!
8.8!
5! 5! 5! 5! 5!
10%!SDS! 0.2! 0.2! 0.2! 0.2! 0.2!
40%!
Acrylamide!












































































































































































































































































































































Component( Volume( Component( Volume(




Distiled!Water! 8mL! 250mM!Luminol! 200uL!

















































































































































































































































































































































12Qwel! 0.5!ml! 1.0!ml! 0.5!ml! !
6Qwel! 1.0!ml! 1.5!ml! 1.0!ml! !
60!mm!dish! 2.0!ml! 2.5!ml! 0.5!ml! !
T25!flask! 2.5!ml! 5.0!ml! 2.0!ml! !
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MAD!–!Mesenchymal!Alternative!Diferentiation!!
MG!–!Matrigel!
MOP!–!Myositis!Ossficicans!Progressiva!
MOT!–!Myositis!Ossificans!Traumatica!
MPC!–!Muscle!Precursor!Cel!
MSC!–!Mesenchymal!Stem!Cel!
NBT!–!Nitroblue!Tetrazolium!
NSAID!–!NonQSteroidal!AntiQInflammatory!Drugs!
PEGQCat–!Polyethylene!GlycolQCatalase!
PEI!–!Poly(ethyleneimine)!
PGEQ2!–!Prostaglandin!E2!
pNPP!–!pQNitrophenyl!phosphate!
PPM!–!PreQPlate!Media!
RDA!Q!Recommended!Dietary!Alowance!
ROSQ!Reactive!Oxygen!Species!
RT!–!Room!Temperature!!
SEM!–!standard!eror!of!mean!!
SOD!–!Superoxide!Dismutase!
TEMPOL!–!4QHydroxyQTEMPO!
WR!–!Working!Reagent 
!
!
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